Literature DB >> 26694925

Management of postoperative bladder emptying after proctectomy in men for rectal cancer. A retrospective study of 190 consecutive patients.

Cécile Bouchet-Doumenq1, Jérémie H Lefevre2, Malika Bennis1, Najim Chafai1, Emmanuel Tiret1, Yann Parc1.   

Abstract

PURPOSE: Evaluation of urinary drainage after rectal resection and identification of criteria associated with postoperative urinary dysfunction (UD). UD remains a clinical problem for up to two thirds of patients after rectal resection. Currently, there are no guidelines concerning duration or type of drainage.
METHODS: One hundred ninety consecutive rectal resections (abdomino-perineal resection (APR = 47), mechanical coloanal anastomosis (MechCAA = 48), manual coloanal anastomosis (ManCAA = 47), colorectal anastomosis (CRA = 48)) in male patients were included. In patients with a transurethral catheterization (TUC), the drainage was removed at day 5. Patients with a suprapubic catheterization (SPC) underwent drainage removal according to the results of a clamping test at day 5. UD was defined as drainage removal after day 6 and/or acute urinary retention (AUR).
RESULTS: Drainage types were SPC (n = 136, 72%) and TUC (n = 54, 28%). SPC was used more frequently after total mesorectal excision (TME) (APR, ManCAA, MechCAA) (83-92%). Complications rates of SPC and TUC were 20 and 9%. The clamping test was positive for 61 patients (48%), and SPC was removed before/on POD6 without any episode of AUR. After TUC removal, two patients (4%) had AUR. Seventy-two (38%) patients had UD: 11 (6%) were discharged with an indwelling catheter, and in 61 (32%), the catheter was removed after day6. Three independent factors were associated with UD: diabetes (OR = 2.9 (1.2-7.7)), urological history (OR = 2.9 (1.2-7.6)), and TME (OR = 5.2 (2.3-13.5)).
CONCLUSION: The UD rate after surgery for rectal cancer was 38%. The clamping test is accurate to prevent AUR after SPC removal. The three risk factors may serve to select good candidates for early catheter removal.

Entities:  

Keywords:  Colorectal anastomosis; Rectal cancer; Suprapubic catheterization; Transurethral catheterization; Urinary dysfunction

Mesh:

Year:  2015        PMID: 26694925     DOI: 10.1007/s00384-015-2471-8

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  23 in total

1.  Morbidity risk factors after low anterior resection with total mesorectal excision and coloanal anastomosis: a retrospective series of 483 patients.

Authors:  Malika Bennis; Yann Parc; Jérémie H Lefevre; Najim Chafai; Emmanuel Attal; Emmanuel Tiret
Journal:  Ann Surg       Date:  2012-03       Impact factor: 12.969

2.  Radical and nerve-preserving surgery for rectal cancer in The Netherlands: a prospective study on morbidity and functional outcome.

Authors:  C P Maas; Y Moriya; W H Steup; G M Kiebert; W M Kranenbarg; C J van de Velde
Journal:  Br J Surg       Date:  1998-01       Impact factor: 6.939

3.  Suprapubic versus transurethral catheterisation of males undergoing pelvic colorectal surgery.

Authors:  C D Ratnaval; P Renwick; R Farouk; J R Monson; P W Lee
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

4.  Prospective randomized controlled trial of urethral versus suprapubic catheterization.

Authors:  K K Sethia; J B Selkon; A R Berry; C M Turner; M G Kettlewell; M H Gough
Journal:  Br J Surg       Date:  1987-07       Impact factor: 6.939

5.  Total mesorectal excision is optimal surgery for rectal cancer: a Scandinavian consensus.

Authors:  R J Heald
Journal:  Br J Surg       Date:  1995-10       Impact factor: 6.939

6.  Urinary bladder catheter drainage following pelvic surgery--is it necessary for that long?

Authors:  Oded Zmora; Khaled Madbouly; Hagit Tulchinsky; Ahmed Hussein; Marat Khaikin
Journal:  Dis Colon Rectum       Date:  2010-03       Impact factor: 4.585

7.  Postoperative urinary retention after primary colorectal cancer resection via laparotomy: a prospective study of 2,355 consecutive patients.

Authors:  Chung Rong Changchien; Chien Yuh Yeh; Shih Tsung Huang; Ming-Li Hsieh; Jinn-Shiun Chen; Reiping Tang
Journal:  Dis Colon Rectum       Date:  2007-10       Impact factor: 4.585

8.  Risk factors for developing voiding dysfunction after abdominoperineal resection for adenocarcinoma of the rectum.

Authors:  F J Burgos; J Romero; E Fernandez; L Perales; M Tallada
Journal:  Dis Colon Rectum       Date:  1988-09       Impact factor: 4.585

9.  Continuous preperitoneal infusion of ropivacaine provides effective analgesia and accelerates recovery after colorectal surgery: a randomized, double-blind, placebo-controlled study.

Authors:  Marc Beaussier; Hanna El'Ayoubi; Eduardo Schiffer; Maxime Rollin; Yann Parc; Jean-Xavier Mazoit; Louisa Azizi; Pascal Gervaz; Serge Rohr; Celine Biermann; André Lienhart; Jean-Jacques Eledjam
Journal:  Anesthesiology       Date:  2007-09       Impact factor: 7.892

10.  French guidelines for enhanced recovery after elective colorectal surgery.

Authors:  P Alfonsi; K Slim; M Chauvin; P Mariani; J L Faucheron; D Fletcher
Journal:  J Visc Surg       Date:  2013-12-27       Impact factor: 2.043

View more
  3 in total

Review 1.  Overlooked Long-Term Complications of Colorectal Surgery.

Authors:  Matthew D Giglia; Sharon L Stein
Journal:  Clin Colon Rectal Surg       Date:  2019-04-02

2.  Correlation Analyses of Computed Tomography and Magnetic Resonance Imaging for Calculation of Prostate Volume in Colorectal Cancer Patients with Voiding Problems Who Cannot Have Transrectal Ultrasonography.

Authors:  Sung Han Kim; Boram Park; Whi-An Kwon; Jae Young Joung; Ho Kyung Seo; Jinsoo Chung; Kang Hyun Lee
Journal:  Biomed Res Int       Date:  2019-03-31       Impact factor: 3.411

3.  Suprapubic bladder drainage and epidural catheters following abdominal surgery-A risk for urinary tract infections?

Authors:  Johanna Wagner; Barbara Eiken; Imme Haubitz; Sven Lichthardt; Niels Matthes; Stefan Löb; Ingo Klein; Christoph-Thomas Germer; Armin Wiegering
Journal:  PLoS One       Date:  2019-01-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.